- Case report
- Open Access
Dexmedetomidine-treated hyperventilation syndrome triggered by the distress related with a urinary catheter after general anesthesia: a case report
JA Clinical Reports volume 3, Article number: 22 (2017)
Hyperventilation syndrome (HVS) sometimes occurs in patients under stressful conditions and may provoke severe complications such as myocardial infarction and death. The authors report a case of HVS following general anesthesia, where a continuous intravenous infusion of dexmedetomidine was effective for HVS.
A 23-year-old male patient with recurrent tongue cancer was scheduled to undergo partial glossectomy and neck dissection. Emergence from general anesthesia was prompt. Twenty-two minutes after extubation, the patient complained of unbearable distress caused by the urinary catheter. He began to cry, with an increased respiratory rate of over 40 breaths per minute. Intravenous infusion of flurbiprofen, droperidol, and morphine was not effective. Electrocardiography and laryngofiberscopy indicated the absence of acute coronary syndrome and airway obstruction, respectively. An arterial blood gas determination showed pH 7.63, PaCO2 18.2 mmHg, PaO2 143 mmHg on O2 mask 4 L/min, Ca2+ 4.29 mmol/L, and lactate 3.4 mmol/L. The patient was diagnosed with HVS. Dexmedetomidine infusion 2.0 μg/kg/h for 10 min followed by 0.7 μg/kg/h reduced respiratory rate, suppressed arousal, and disappeared the complaint of bladder distension. One hour after extubation, an arterial blood gas determination showed pH 7.33, PaCO2 51.3 mmHg, PaO2 196 mmHg on O2 mask 4 L/min, Ca2+ 4.70 mmol/L, and lactate 1.5 mmol/L. After admission to the intensive care unit, dexmedetomidine infusion was maintained at the rate of 0.2 to 0.7 μg/kg/h until the following morning, and he did not complain of distress caused by the urinary catheter.
HVS can occur after emergence from general anesthesia, and dexmedetomidine infusion was effective for HVS.
Hyperventilation syndrome (HVS) may occur in relatively young patients under a stressful condition. HVS is usually considered to be benign; however, hyperventilation and subsequent respiratory alkalosis may provoke severe complications such as myocardial infarction and death [1,2,3,4]. Thus, early diagnosis and treatment is essential to prevent these complications. The authors report a case of HVS triggered by distress caused by the urinary catheter after otolaryngologic surgery. Continuous intravenous infusion of dexmedetomidine was effective for hyperventilation and control of symptoms.
A 23-year-old male patient with recurrent tongue cancer was scheduled to undergo partial glossectomy and neck dissection. His height and body weight were 171 cm and 76.1 kg, respectively. He had no history of psychiatric disease or HVS. Throughout the general anesthesia, the following variables were monitored continuously: electrocardiogram (ECG), peripheral oxygen saturation (SpO2), end-tidal concentration of carbon dioxide. left radial artery pressure, rectal temperature, and bispectral index. Anesthesia was induced and maintained with propofol (3–6 mg/kg/h), ketamine (70 mg), remifentanil (0.15–0.5 μg/kg/min), and rocuronium (50 mg). To reduce postoperative pain, fentanyl 200 μg and acetaminophen 1000 mg were intravenously administered 30 min before the end of the surgery. Emergence from general anesthesia was prompt, and the trachea was extubated. An initial arterial blood gas determination showed pH 7.38, PaCO2 45.2 mmHg, PaO2 193 mmHg on O2 mask 4 L/min, Ca2+ 4.70 mmol/L, and lactate 1.3 mmol/L 10 min after extubation. Twenty-two minutes after extubation, the patient complained of unbearable distress caused by the urinary catheter. Though flurbiprofen axetil 50 mg was intravenously administered, the symptom did not improve but gradually increased. The patient began to cry and his voice was hoarse, with an increased respiratory rate over 40 breaths per minute. The ECG revealed normal sinus tachycardia (HR 100–120 bpm) without ST segment changes. A laryngofiberscopy indicated an absence of vocal fold paralysis and laryngeal edema. The patient was diagnosed with HVS. Although droperidol 5 mg and morphine 10 mg were intravenously administered, hyperventilation did not improve. An arterial blood gas determination showed pH 7.63, PaCO2 18.2 mmHg, PaO2 143 mmHg on O2 mask 4 L/min, Ca2+ 4.29 mmol/L, and lactate 3.4 mmol/L. Thirty-five minutes after extubation, continuous sedation with dexmedetomidine was selected to treat hyperventilation and symptoms. Dexmedetomidine infusion 2.0 μg/kg/h for 10 min followed by 0.7 μg/kg/h reduced respiratory rate, suppressed arousal, and disappeared the complaint of bladder distension. Even though apnea (≦4 breaths per minute) after hyperventilation appeared for 3 min, SpO2 was maintained at 90% or above. One hour after extubation, arterial blood gas analysis showed pH 7.33, PaCO2 51.3 mmHg, PaO2 196 mmHg on O2 mask 4 L/min, Ca2+ 4.70 mmol/L, and lactate 1.5 mmol/L. After admission to the intensive care unit, dexmedetomidine infusion was maintained at the rate of 0.2 to 0.7 μg/kg/h until the following morning, and he did not complain of distress caused by the urinary catheter.
This case provided two important clinical issues. First, HVS can occur after emergence from general anesthesia. This syndrome is a common disease as indicated in a study by Jones et al., estimating a prevalence of 9.5% in an adult population  and sometimes occurring during dental care [6, 7]. However, HVS after general anesthesia is less common because sedative drugs and opioids provide an anxiolytic and antiadrenergic action and relief of pain. Mizuno and colleagues  reported a case in which HVS developed before induction of and after emergence from general anesthesia. The authors considered that this syndrome could occur repeatedly under anxiety and stressful conditions even if a patient had no previous history of psychiatric disease. In this case, potential anxiety about tongue cancer induced HVS triggered by bladder distension. Anesthesiologists should consider that HVS can occur even after general anesthesia.
Although HVS is a common disease, HVS is a disorder with no widely accepted diagnostic criteria . Thus, it is diagnosed by the exclusion of alternative possibilities such as metabolic and cardiopulmonary diseases, asthma, pneumothorax, airway obstruction, and acute coronary syndrome. In this case, ECG, laryngofiberscopy, and arterial blood gas analysis ruled out these diseases and he was diagnosed with HVS. However, delirium or agitation also occurs after general anesthesia and differential diagnosis between them is difficult, and the overlap of delirium or agitation that are associated with hyperventilation should be kept in mind. Delirium is associated with increased mortality, prolonged hospital stay, and persistent cognitive dysfunction [10, 11]. Early diagnosis and treatment for altered mental status occurring in the postoperative period after emergence from general anesthesia are important.
Second, dexmedetomidine infusion was effective for HVS. Dexmedetomidine is an α-adrenergic agonist with dose-dependent α2-adrenoceptor selectivity. It seems that the mechanism of action of the drug is suitable to treat HVS. Pre- and post-synaptic activation of α2-adrenoceptor inhibits the release of norepinephrine and sympathetic activity and terminates the transmission of pain signals . These effects produce sedation, analgesia, and anxiolysis. Furthermore, α2-adrenoceptor inhibits the release of serotonin in the rostral raphe nuclei which is associated with arousal and fear which are associated with panic disorder or others . A large randomized control study revealed that dexmedetomidine reduced the incidence of postoperative delirium by 14% in patients aged over 65 years . In addition to analgesic and anxiolytic properties of dexmedetomidine, its anti-inflammatory action might have treated both HVS and delirium. Elevated biomarkers of inflammation have associated with the risk for developing delirium . Anti-inflammatory effects of dexmedetomidine were evident in both clinical and animal studies [16, 17]. Furthermore, dexmedetomidine has advantages over other sedating agents because of minimal suppression of respiratory function . In this case, the bladder might have been kept distended until the next morning and upper airway obstruction and respiratory depression after neck dissection were one of several concerns. Taking these factors into consideration, the drug may be considered to be a good choice for sedation for HVS after general anesthesia. Dexmedetomidine can be an option to treat and prevent an altered mental state occurring in the postoperative period after emergence from general anesthesia.
HVS can occur after emergence from general anesthesia, and dexmedetomidine infusion was effective for hyperventilation syndrome. Clinical studies and case report accumulation are required to confirm the usefulness of dexmedetomidine for HVS after general anesthesia.
Fangio P, De Jonghe B, Lachérade JC, Terville JP, Outin H. Coronary spasm in a 59-yr-old woman with hyperventilation. Can J Anaesth. 2004;51:850–1.
Chelmowski MK, Keelan Jr MH. Hyperventilation and myocardial infarction. Chest. 1988;93:1095–6.
Bouras N, Kartsouns LD, Bridges PK. Death associated with hyperventilation. Lancet. 1987;1:635–6.
Bates JH, Adamson JS, Pierge JA. Death after voluntary hyperventilation. N Engl J Med. 1966;274:1371–2.
Jones M, Harvey A, Marston L, O'Connell NE. Breathing exercises for dysfunctional breathing/hyperventilation syndrome in adults. Cochrane Database Syst Rev. 2013;31, CD009041. doi:10.1002/14651858.
Tomioka S, Takechi M, Ohshita N, Nakajo N. Propofol is not effective for hyperventilation syndrome. Anesth Analg. 2001;92:781–2.
Kobayashi M, Kurata S, Sanuki T, Okayasu I, Ayuse T. Management of post-hyperventilation apnea during dental treatment under monitored anesthesia care with propofol. Bio Psycho Social Medicine. 2014;14:26.
Mizuno J, Morita S, Itou Y, Honda M, Momoeda K, Hanaoka K. Hyperventilation syndrome before induction of and after awakening from general anesthesia. Masui. 2009;58:768–71.
Lewis RA, Howell JB. Definition of the hyperventilation syndrome. Bull Eur Physiopathol Respir. 1986;22:201.
Witlox J, Eurelings LS, de Jonghe JF, Kalisvaart KJ, Eikelenboom P, van Gool WA. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010;304:443–51.
Saczynski JS, Marcantonio ER, Quach L, Fong TG, Gross A, Inouye SK, Jones RN. Cognitive trajectories after postoperative delirium. N Engl J Med. 2012;367:30–9.
Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent). 2001;14:13–21.
Hopwood SE, Stamford JA. Noradrenergic modulation of serotonin release in rat dorsal and median raphé nuclei via alpha(1) and alpha(2A) adrenoceptors. Neuropharmacology. 2001;41:433–42.
Su X, Meng ZT, Wu XH, Cui F, Li HL, Wang DX, Zhu X, Zhu SN, Maze M, Ma D. Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial. Lancet. 2016;388:1893–902.
Capri M, Yani SL, Chattat R, Fortuna D, Bucci L, Lanzarini C, Morsiani C, Catena F, Ansaloni L, Adversi M, Melotti MR, Di Nino G, Franceschi C. Pre-operative, high-IL-6 blood level is a risk factor of post-operative delirium onset in old patients. Front Endocrinol (Lausanne). 2014;5:173.
Memiş D, Hekimoğlu S, Vatan I, Yandim T, Yüksel M, Süt N. Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients. Br J Anaesth. 2007;98:550–2. Inflammation. 2014;37:1763–70.
Xiang H, Hu B, Li Z, Li J. Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.
Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care. 2000;4:302–8.
We are grateful to signed professor Phillip Evans, BSc, MSc, MEd, FHEA for his valuable comments.
JS drafted the manuscript. EA and KH revised the manuscript. All authors read and approved the final manuscript for submission.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.